National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

cladribine
A purine nucleoside antimetabolite analogue. Cladribine triphosphate, a phosphorylated metabolite of cladribine, incorporates into DNA, resulting in single-strand breaks in DNA, depletion of nicotinamide adenine dinucleotide (NAD) and adenosine triphosphate (ATP), and apoptosis. Because this agent is resistant to adenosine deaminase, an enzyme that inactivates some antineoplastic agents, it is selectively toxic to lymphocytes and monocytes which exhibit little deoxynucleotide deaminase activity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Cladribina
US brand name:Leustatin
Foreign brand names:Leustat
Leustatine
Abbreviations:2CDA
2-CdA
Code name:RWJ-26251
Chemical structure names:
  • 2-chloro-2-deoxyadenosine
  • 2-chlorodeoxyadenosine



Previous:cisplatin-e therapeutic implant, Cistane, citalopram hydrobromide, Citracal, Citroma
Next:Clafen, Claforan, Claravis, clarithromycin, Class 1 PI3K kinase family inhibitor XL147

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov